EDITORIAL
Published on 04 Aug 2022
Editorial: Natural products as drivers in drug development for neurodegenerative disorders
doi 10.3389/fphar.2022.932179
- 1,102 views
- 1 citation
- Frontiers in Pharmacology
- Ethnopharmacology
- Research Topics
- Natural Products as Drivers in Drug Development for Neurodegenerative Disorders
Natural Products as Drivers in Drug Development for Neurodegenerative Disorders
10k
Total downloads
41k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 04 May 2022
Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
doi 10.3389/fphar.2022.876614
- 6,039 views
- 30 citations
ORIGINAL RESEARCH
Published on 24 Feb 2022
Meridianins Rescue Cognitive Deficits, Spine Density and Neuroinflammation in the 5xFAD Model of Alzheimer’s Disease
doi 10.3389/fphar.2022.791666
- 2,182 views
- 7 citations
ORIGINAL RESEARCH
Published on 14 Feb 2022
Total Triterpenes of Wolfiporia cocos (Schwein.) Ryvarden & Gilb Exerts Antidepressant-Like Effects in a Chronic Unpredictable Mild Stress Rat Model and Regulates the Levels of Neurotransmitters, HPA Axis and NLRP3 Pathway
doi 10.3389/fphar.2022.793525
- 2,641 views
- 4 citations
ORIGINAL RESEARCH
Published on 06 Jan 2022
Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model
doi 10.3389/fnins.2021.803927
- 3,085 views
- 5 citations
REVIEW
Published on 04 Nov 2021
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease
doi 10.3389/fphar.2021.775034
- 15,679 views
- 50 citations
REVIEW
Published on 26 Oct 2021
Modulating Neurological Complications of Emerging Infectious Diseases: Mechanistic Approaches to Candidate Phytochemicals
doi 10.3389/fphar.2021.742146
- 2,609 views
- 4 citations
ORIGINAL RESEARCH
Published on 06 Sep 2021
A Novel 5-HT1B Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease
doi 10.3389/fphar.2021.735876
- 5,536 views
- 7 citations
Published in
Frontiers in Pharmacology
- Ethnopharmacology
- Neuropharmacology
- Experimental Pharmacology and Drug Discovery
Participating Journals
Frontiers in Neurology
NeuropharmacologyOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Neuroscience
- 3.2 impact factor
- 6.2 citescore
Frontiers in Psychiatry
NeuropharmacologyOffline
- 3.2 impact factor
- 6.2 citescore
Impact
- 41kTopic views
- 30kArticle views
- 10kArticle downloads